21 Stocks Moving in Monday’s Pre-Market Session
Gainers
Itamar Medical Ltd. (NASDAQ: ITMR) rose 43% to $29.52 in pre-market trading. Zoll Medical said it has signed an agreement to acquire Itamar Medical for $31 per ADS in cash.
Itamar Medical Goes Private In $538M Deal: All You Need To Know
ZOLL Medical Corporation, an Asahi Kasei company, has agreed to acquire Itamar Medical Ltd (NASDAQ:ITMR) for a total value of approximately $538 million.…
Itamar Medical Shares +42% Premarket; Zoll Medical Says Signed Agreement to Acquire Itamar Medical for $31/ADS in Cash
ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Itamar™ Medical Ltd.
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios’ Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 16)
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck’s Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 9)
Itamar Medical: Q2 Earnings Insights
Shares of Itamar Medical (NASDAQ:ITMR) remained unaffected after the company reported Q2 results.
Quarterly Results
Earnings per share decreased 17.65% year over year to ($0.20), which beat the estimate of ($0.29).
Itamar Medical Q2 ADS $(0.20) Beats $(0.29) Estimate, Sales $12.60M Beat $11.80M Estimate
Itamar Medical (NASDAQ:ITMR) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.29) by 31.03 percent. This is a 17.65 percent decrease over losses of $(0.17) per share from